semaglutide weekly results JOURNEY RECAP // How I lost 30 lbs in 3 months, milestones, challenges + sustainability Semaglutide Review: 'The Drug Helped
Description
20251222(FDA)(GLP-1)Novo NordiskWegovy
Many individuals experience energy dips during GLP-1 therapy
Novo Nordisks Ozempic has secured a new FDA approval, expanding its use to reduce the risk of kidney disease in diabetic and CKD patients.
Tirzepatide acts as glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic peptide (GIP) receptor agonist, making it an effective treatment of type 2 diabetes with hypoglycemic and we...
An everything-but-the-kitchen-sink mapping study of GLP1- receptor agonists compared to other diabetes medications, where 175 health outcomes were assessed between the two groups, was published this year and it highlighted a number of slight risk increases with GLP-1 receptor agonists
We are just starting to learn more about the systemic impact of these medications, Dr
